Roflumilast (Daliresp®) to Reduce Acute Pulmonary Events in Fibrotic Sarcoidosis: A Multi-Center, Double Blind, Placebo Controlled, Randomized Clinical Trial. Sarcoidosis Vasc Diffuse Lung Dis 2021, 38 (3), e2021035. https://doi.org/10.36141/svdld.v38i3.11684.